IDEAS home Printed from https://ideas.repec.org/a/nas/journl/v117y2020p1917-1923.html
   My bibliography  Save this article

Predicting high-risk opioid prescriptions before they are given

Author

Listed:
  • Justine S. Hastings

    (Research Improving People’s Lives, Providence, RI02903; Watson Institute for International and Public Affairs, Brown University, Providence, RI02912; Department of Economics, Brown University, Providence, RI02912; National Bureau of Economic Research, Cambridge, MA02138)

  • Mark Howison

    (Research Improving People’s Lives, Providence, RI02903; Watson Institute for International and Public Affairs, Brown University, Providence, RI02912)

  • Sarah E. Inman

    (Research Improving People’s Lives, Providence, RI02903; School of International and Public Affairs, Columbia University, New York, NY10027)

Abstract

Misuse of prescription opioids is a leading cause of premature death in the United States. We use state government administrative data and machine learning methods to examine whether the risk of future opioid dependence, abuse, or poisoning can be predicted in advance of an initial opioid prescription. Our models accurately predict these outcomes and identify particular prior nonopioid prescriptions, medical history, incarceration, and demographics as strong predictors. Using our estimates, we simulate a hypothetical policy which restricts new opioid prescriptions to only those with low predicted risk. The policy’s potential benefits likely outweigh costs across demographic subgroups, even for lenient definitions of “high risk.” Our findings suggest new avenues for prevention using state administrative data, which could aid providers in making better, data-informed decisions when weighing the medical benefits of opioid therapy against the risks.

Suggested Citation

  • Justine S. Hastings & Mark Howison & Sarah E. Inman, 2020. "Predicting high-risk opioid prescriptions before they are given," Proceedings of the National Academy of Sciences, Proceedings of the National Academy of Sciences, vol. 117(4), pages 1917-1923, January.
  • Handle: RePEc:nas:journl:v:117:y:2020:p:1917-1923
    as

    Download full text from publisher

    File URL: http://www.pnas.org/content/117/4/1917.full
    Download Restriction: no
    ---><---

    Other versions of this item:

    References listed on IDEAS

    as
    1. Hastings, Justine S. & Howison, Mark & Lawless, Ted & Ucles, John & White, Preston & Research Improving People's Lives, (RIPL), 2019. "Unlocking Data to Improve Public Policy," OSF Preprints 28krq, Center for Open Science.
    2. Abby Alpert & David Powell & Rosalie Liccardo Pacula, 2017. "Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids," NBER Working Papers 23031, National Bureau of Economic Research, Inc.
    3. Abby Alpert & David Powell & Rosalie Liccardo Pacula, 2018. "Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids," American Economic Journal: Economic Policy, American Economic Association, vol. 10(4), pages 1-35, November.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Michael Allan Ribers & Hannes Ullrich, 2020. "Machine Predictions and Human Decisions with Variation in Payoffs and Skill," CESifo Working Paper Series 8702, CESifo.
    2. Michael Allan Ribers & Hannes Ullrich, 2019. "Battling Antibiotic Resistance: Can Machine Learning Improve Prescribing?," Papers 1906.03044, arXiv.org.
    3. Michael Allan Ribers & Hannes Ullrich, 2023. "Machine learning and physician prescribing: a path to reduced antibiotic use," Berlin School of Economics Discussion Papers 0019, Berlin School of Economics.
    4. Margrét Vilborg Bjarnadóttir & David B. Anderson & Ritu Agarwal & D. Alan Nelson, 2022. "Aiding the prescriber: developing a machine learning approach to personalized risk modeling for chronic opioid therapy amongst US Army soldiers," Health Care Management Science, Springer, vol. 25(4), pages 649-665, December.
    5. Shan Huang & Michael Allan Ribers & Hannes Ullrich, 2021. "The Value of Data for Prediction Policy Problems: Evidence from Antibiotic Prescribing," Discussion Papers of DIW Berlin 1939, DIW Berlin, German Institute for Economic Research.
    6. Wei-Hsuan Lo-Ciganic & James L Huang & Hao H Zhang & Jeremy C Weiss & C Kent Kwoh & Julie M Donohue & Adam J Gordon & Gerald Cochran & Daniel C Malone & Courtney C Kuza & Walid F Gellad, 2020. "Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: A prognostic study," PLOS ONE, Public Library of Science, vol. 15(7), pages 1-16, July.
    7. Huang, Shan & Ribers, Michael Allan & Ullrich, Hannes, 2022. "Assessing the value of data for prediction policies: The case of antibiotic prescribing," Economics Letters, Elsevier, vol. 213(C).

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Gihleb, Rania & Giuntella, Osea & Zhang, Ning, 2020. "Prescription drug monitoring programs and neonatal outcomes," Regional Science and Urban Economics, Elsevier, vol. 81(C).
    2. Kalbfuss, Jörg & Odermatt, Reto & Stutzer, Alois, 2024. "Medical marijuana laws and mental health in the United States," Health Economics, Policy and Law, Cambridge University Press, vol. 19(3), pages 307-322, July.
    3. Molly Schnell & Janet Currie, 2018. "Addressing the Opioid Epidemic: Is There a Role for Physician Education?," American Journal of Health Economics, MIT Press, vol. 4(3), pages 383-410, Summer.
    4. Borgschulte, Mark & Corredor-Waldron, Adriana & Marshall, Guillermo, 2018. "A path out: Prescription drug abuse, treatment, and suicide," Journal of Economic Behavior & Organization, Elsevier, vol. 149(C), pages 169-184.
    5. Boslett, Andrew & Hill, Elaine, 2022. "Mortality during resource booms and busts," Journal of Environmental Economics and Management, Elsevier, vol. 115(C).
    6. Mitchell, Penelope & Samsel, Steven & Curtin, Kevin M. & Price, Ashleigh & Turner, Daniel & Tramp, Ryan & Hudnall, Matthew & Parton, Jason & Lewis, Dwight, 2022. "Geographic disparities in access to Medication for Opioid Use Disorder across US census tracts based on treatment utilization behavior," Social Science & Medicine, Elsevier, vol. 302(C).
    7. Suppliet, Moritz, 2020. "Umbrella branding in pharmaceutical markets," Journal of Health Economics, Elsevier, vol. 73(C).
    8. Mark McInerney, 2017. "The Affordable Care Act, Public Insurance Expansion and Opioid Overdose Mortality," Working papers 2017-23, University of Connecticut, Department of Economics.
    9. Shiyu Zhang & Daniel Guth, 2021. "The OxyContin Reformulation Revisited: New Evidence From Improved Definitions of Markets and Substitutes," Papers 2101.01128, arXiv.org, revised Jan 2021.
    10. Aparna Keshaviah & Editor, "undated". "Special Report: The Potential of Wastewater Testing for Public Health and Safety," Mathematica Policy Research Reports 5a867fbc382040a1af74f957b, Mathematica Policy Research.
    11. Gihleb, Rania & Giuntella, Osea & Zhang, Ning, 2018. "The Effects of Mandatory Prescription Drug Monitoring Programs on Foster Care Admissions," IZA Discussion Papers 11470, Institute of Labor Economics (IZA).
    12. Christopher J. Ruhm, 2018. "Deaths of Despair or Drug Problems?," NBER Working Papers 24188, National Bureau of Economic Research, Inc.
    13. McMichael, Benjamin J. & Van Horn, R. Lawrence & Viscusi, W. Kip, 2020. "The impact of cannabis access laws on opioid prescribing," Journal of Health Economics, Elsevier, vol. 69(C).
    14. Doleac, Jennifer & Mukherjee, Anita, 2018. "The Moral Hazard of Lifesaving Innovations: Naloxone Access, Opioid Abuse, and Crime," IZA Discussion Papers 11489, Institute of Labor Economics (IZA).
    15. Bullinger, Lindsey Rose & Wing, Coady, 2019. "How many children live with adults with opioid use disorder?," Children and Youth Services Review, Elsevier, vol. 104(C), pages 1-1.
    16. Pohl, R. Vincent, 2018. "Time Trends Matter: The Case of Medical Cannabis Laws and Opioid Overdose Mortality," MPRA Paper 88219, University Library of Munich, Germany.
    17. Meinhofer, Angélica & Witman, Allison E., 2018. "The role of health insurance on treatment for opioid use disorders: Evidence from the Affordable Care Act Medicaid expansion," Journal of Health Economics, Elsevier, vol. 60(C), pages 177-197.
    18. Daniel I. Rees & Joseph J. Sabia & Laura M. Argys & Joshua Latshaw & Dhaval Dave, 2017. "With a Little Help from My Friends: The Effects of Naloxone Access and Good Samaritan Laws on Opioid-Related Deaths," NBER Working Papers 23171, National Bureau of Economic Research, Inc.
    19. Louis‐Philippe Beland & Jason Huh & Dongwoo Kim, 2024. "The effect of opioid use on traffic fatalities," Health Economics, John Wiley & Sons, Ltd., vol. 33(6), pages 1123-1132, June.
    20. Adamopoulou, Effrosyni & Greenwood, Jeremy & Guner, Nezih & Kopecky, Karen, 2024. "The Role of Friends in the Opioid Epidemic," CEPR Discussion Papers 18803, C.E.P.R. Discussion Papers.

    More about this item

    Keywords

    opioids; evidence-based policy; predictive modeling; machine learning; administrative data;
    All these keywords.

    JEL classification:

    • D61 - Microeconomics - - Welfare Economics - - - Allocative Efficiency; Cost-Benefit Analysis
    • I1 - Health, Education, and Welfare - - Health
    • I12 - Health, Education, and Welfare - - Health - - - Health Behavior
    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
    • Z18 - Other Special Topics - - Cultural Economics - - - Public Policy

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nas:journl:v:117:y:2020:p:1917-1923. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Eric Cain (email available below). General contact details of provider: http://www.pnas.org/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.